Teen's Max Catch Minis

Teen's Max Catch Minis

Carlson4.9 (378 ratings)
Format:Softgel Quantity: 60 Softgel(s) · 30 servings
Goals
$31.92 $1.06 per serving

Product analysis

46 out of 100

Teen's Max Catch Minis supplies EPA and DHA for omega-3 intake, though expected benefits depend on the purpose and individual circumstances. Their content is relatively expensive, and adult research does not establish the same benefits in teenagers.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

EPA and DHA amounts are identified, but their forms are not disclosed clearly on the label. That leaves the preparation less straightforward to compare despite the known active content.

Ingredient Transparency70

The active amounts and composition are disclosed, making the EPA and DHA content clear. Missing form details still limit a complete comparison of the oil preparation.

Value For Money16

Both EPA and DHA are relatively expensive for the content supplied. Clear active amounts help make that comparison without relying on the total oil amount.

Customer Satisfaction80

Customer feedback is very positive across several hundred ratings. That describes satisfaction without establishing teenage health benefits.

Product Focus70

EPA and DHA give the formula a recognizable omega-3 purpose. Benefits for focus, joints and other uses remain dependent on context, and adult findings should not be assumed to apply to teenagers.

Format
Softgel
Container
60 Softgel(s)
Per serving
$1.06
Customer rating
4.9 · 378 ratings
Report analysis

Goals

Impact
High effect
B- Ingredient FitC- PathwaysA+ EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 600 mg
Study evidence
Skin Health
Impact
High effect
A Ingredient FitD PathwaysB EvidenceA+ Formulation Logic
Omega-3 · 1000 mg
Study evidence
Omega-3 Supportive 35 studies
Joint Health
Impact
Moderate effect
C+ Ingredient FitF PathwaysC+ EvidenceA+ Formulation Logic
Omega-3 · 1000 mg
Study evidence
Omega-3 Supportive 40 studies
Metabolism Support
Impact
Moderate effect
D Ingredient FitF PathwaysA- EvidenceA+ Formulation Logic
Omega-3 · 1000 mg
Study evidence
Omega-3 Supportive 42 studies
Impact
High effect
B- Ingredient FitC PathwaysB EvidenceA+ Formulation Logic
EPA (Eicosapentaenoic Acid) · 600 mg
Study evidence
Mental Focus
Impact
High effect
C+ Ingredient FitD+ PathwaysC- EvidenceA+ Formulation Logic
Study evidence

Ingredients

IngredientAmount per servingScore
Calories
15 Calorie(s)
Total Fat
1.5 Gram(s)
Marine Oil concentrate
1250 mg
Total Omega-3 Fatty Acids (reported as Triglycerides)
1000 mg 79
Eicosapentaenoic Acid
600 mg 76
Docosahexaenoic Acid
400 mg 75
Gluten Free Adults 18–50 Children 4+
Report overview
A+ Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyD+ Value
The serving lists 600 mg EPA and 400 mg DHA. The cost per gram of combined EPA and DHA is fairly high. The omega-3s are in triglycerides form.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

The omega-3s are in triglycerides form. An antioxidant is included, though its identity is not specified here.
Molecular Form & Absorption Potential
The omega-3s are in triglycerides form.
Source Purity & Oxidative Protection
A preferred oil source and antioxidant are noted, though their details are not specified here.

Dose, Safety & Label Transparency73

The serving lists 600 mg EPA and 400 mg DHA. The 1000 mg of EPA and DHA makes up about 80% of the 1250 mg oil.
EPA & DHA Label Specificity
The serving lists 600 mg EPA and 400 mg DHA.
Active Ingredient Concentration
The 1000 mg of EPA and DHA makes up about 80% of the 1250 mg oil.
Third-Party Purity Verification
A qualifying independent certification or purity standard is not noted.

Value50

The cost per gram of combined EPA and DHA is fairly high.
Price per 1000mg of EPA+DHA
The cost per gram of combined EPA and DHA is fairly high.
A Active Ingredient Quality & BioavailabilityA Dose, Safety & Label TransparencyF Value
600 mg EPA per serving comes at a high cost per gram of EPA. The molecular form is Triglycerides.
How this ingredient is rated

Active Ingredient Quality & Bioavailability90

EPA is in triglyceride form. EPA makes up about 60.0% of the total omega-3.
Molecular Form and Bioavailability
EPA is in triglyceride form.
EPA Concentration Density
EPA makes up about 60.0% of the total omega-3.
Oxidation Protection
Tocopherol is included as an antioxidant.

Dose, Safety & Label Transparency90

The serving has 600 mg EPA and 400 mg DHA. Third-party contaminant testing or certification is indicated, though the details are unspecified.
Absolute EPA Dose per Serving
Each serving provides 600 mg EPA.
EPA-Centric Ratio
The serving has 600 mg EPA and 400 mg DHA.
Purity and Contaminant Testing
Third-party contaminant testing or certification is indicated, though the details are unspecified.

Value20

The cost per gram of EPA is high.
Price per Gram of EPA
The cost per gram of EPA is high.
DHA · 400 mg OverallScore75
A+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyF Value
It provides 400 mg of DHA per serving at a high cost per amount of DHA. Its triglyceride form is stated. A certification claim is recorded.
How this ingredient is rated

Active Ingredient Quality & Bioavailability100

The DHA is in triglyceride form. An antioxidant is included.
DHA Chemical Form & Bioavailability
The DHA is in triglyceride form.
Oxidation Protection & Stability
An antioxidant is included for protection.
Oil Concentration & Purity
The oil contains 1000 mg of omega-3s in 1250 mg of oil per serving.

Dose, Safety & Label Transparency83

Each serving provides 400 mg of DHA. The source is fish oil.
DHA Absolute Dosage
Each serving provides 400 mg of DHA.
Purity & Heavy Metal Verification
A certification claim is recorded, though the program is not specified here.
Ingredient Source Transparency
The source is fish oil.

Value10

The cost per amount of DHA is high.
Price per Gram of DHA
The cost per amount of DHA is high.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  2. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  3. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  4. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsEye Health forEPA (Eicosapentaenoic Acid)
  5. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledEye Health forEPA (Eicosapentaenoic Acid)
  6. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  7. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  8. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  9. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  10. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  11. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  12. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  13. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  14. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  15. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  16. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  17. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  18. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  19. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  20. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Support forOmega-3